KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eli Lilly (LLY) EBT (2016 - 2025)

Historic EBT for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $8.3 billion.

  • Eli Lilly's EBT rose 6406.72% to $8.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $25.7 billion, marking a year-over-year increase of 10292.67%. This contributed to the annual value of $25.7 billion for FY2025, which is 10292.59% up from last year.
  • As of Q4 2025, Eli Lilly's EBT stood at $8.3 billion, which was up 6406.72% from $7.2 billion recorded in Q3 2025.
  • Eli Lilly's 5-year EBT high stood at $8.3 billion for Q4 2025, and its period low was $427.2 million during Q3 2023.
  • Moreover, its 5-year median value for EBT was $2.1 billion (2022), whereas its average is $2.9 billion.
  • In the last 5 years, Eli Lilly's EBT tumbled by 7271.16% in 2023 and then surged by 35532.61% in 2025.
  • Over the past 5 years, Eli Lilly's EBT (Quarter) stood at $1.8 billion in 2021, then increased by 13.94% to $2.1 billion in 2022, then rose by 19.64% to $2.5 billion in 2023, then surged by 100.87% to $5.0 billion in 2024, then soared by 64.07% to $8.3 billion in 2025.
  • Its last three reported values are $8.3 billion in Q4 2025, $7.2 billion for Q3 2025, and $6.8 billion during Q2 2025.